首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 62 毫秒
1.
2.
主动脉夹层动脉瘤腔内修复术围手术期护理   总被引:1,自引:0,他引:1  
目的:总结腔内修复术治疗主动脉夹层动脉瘤的护理经验。方法:根据主动脉瘤及腔内修复术的特点,对7例行此手术的患者进行基础护理、心理护理、心肺脑监护、血压控制、发热护理、器官供血状况及下肢动脉栓塞的观察和出院指导。结果:手术均获成功,无内漏,无手术死亡,未发生肾功能衰竭及截瘫。7例术后均有不同程度的发热,经及时治疗和护理恢复良好。结论:腔内修复术精心和专业的围手术期观察护理是提高手术疗效的有效保证。  相似文献   

3.
目的:总结腔内修复术治疗主动脉夹层动脉瘤的护理经验。方法:根据主动脉瘤及腔内修复术的特点,对7例行此手术的患者进行基础护理、心理护理、心肺脑监护、血压控制、发热护理、器官供血状况及下肢动脉栓塞的观察和出院指导。结果:手术均获成功,无内漏,无手术死亡,未发生肾功能衰竭及截瘫。7例术后均有不同程度的发热,经及时治疗和护理恢复良好。结论:腔内修复术精心和专业的围手术期观察护理是提高手术疗效的有效保证。  相似文献   

4.
胸主动脉瘤腔内隔绝术与传统手术的护理特点比较   总被引:2,自引:0,他引:2  
胸主动脉夹层动脉瘤腔内隔绝术是近年来血管外科治疗的重大进展 ,我院 1999年 9月~ 2 0 0 1年12月共完成胸主动脉夹层动脉瘤腔内隔绝术 80例 ,完成传统的开胸行人工血管置换术 2 6例。本研究以同期进行的两种手术方式进行对比 ,借此探讨腔内隔绝术的护理特点。资料和方法一、临床资料1999年 9月~ 2 0 0 1年 12月共行胸主动脉瘤手术 10 6例 ,其中传统人工血管置换术 2 6例 ,男 16例 ,女 10例 ,年龄 (37± 10 )岁 ;腔内隔绝术 80例 ,男5 4例 ,女 2 6例 ,年龄 (45± 9)岁。二、术后护理传统手术组患者采用气管插管全麻 ,术后均进入ICU病房…  相似文献   

5.
经尿道前列腺气化电切(TUVP)较传统的开放法前列腺切除术,具有手术时间短、创口小、出血少、恢复快、术后并发症少,生活质量高的优点。目前TUVP已经为国内外治疗前列腺增生症(BPH)的主要方法。我院1997年7月-2002年2月采用经尿道前列腺气化电切术治疗良性前列腺增生症的病人180例,效果良好,针对腔内泌尿外科技术的特点和护理体会,总结如下。  相似文献   

6.
1临床资料患者女,57岁。患者7 d前无明显诱因出现脐周疼痛,伴暗红色便血2次,量约100 mL,未予特殊处理。3 d前患者突发呕血,为暗红色,量约1 000 mL,伴全身乏力、出汗、心悸,无黑矇及意识障碍。当地医院全主动脉CTA示远端腹主动脉瘤,瘤体右侧可疑与肠管相连,腹主动脉瘤破裂。予抗感染、输血、止血等保守治疗3 d,症状无明显好转。于2021年11月29日以“主动脉肠瘘,腹主动脉瘤”收治入院。  相似文献   

7.
8.
心脏外科"一站式"杂交手术是指在具备同时进行影像学检查和常规心脏外科手术条件的"一站式"杂交手术室进行心血管疾病的治疗.它避免了在影像学科室和手术室之间多次转移患者,从而降低了患者多次麻醉和转运可能带来的风险;同时"一站式"杂交手术室,可以即时对手术的疗效进行评价,更有利于指导手术实施[1].因而对患者手术安全、护理配合以及体外循环各环节的衔接要求更高.  相似文献   

9.
经皮冠状动脉腔内成形术 (PTCA)是一种安全有效的冠心病的诊疗技术。它以创伤小、诊断明确、疗效显著的特点 ,成为冠心病血运重建的一重要方面。我们通过围手术期给予连续性的护理干预 ,并不断改进护理技术 ,促进了手术的顺利进行 ,预防和减少了并发症的发生 ,减轻了病人的痛苦。1 临床资料我科于 2 0 0 1年 11月~ 2 0 0 2年 7月进行择期PTCA共 46例 ,其中男 2 7例 ,女 19例 ,年龄 5 2~ 78岁 ,平均 64 .2 3岁。单支病变 16例 ,双支病变 2 3例 ,三支病变 7例。实施球囊扩张43次 ,3 4例病人放支架 41个。术后经冠状动脉造影证实狭窄程…  相似文献   

10.
95 %以上的腹主动脉瘤 (AAA)是由于动脉粥样硬化所引起 ,有破裂致死的危险。今年 ,我院开展AAA腔内隔绝术 (EVE) ,效果满意。较传统手术方法 ,其具有创伤小 ,恢复快 ,住院时间短的优点。现将本手术的护理介绍如下。一、临床资料本组 6例 ,均为男性 ,年龄 4 6~ 76岁 ,平均 5 9岁。术前均不同程度合并有冠心病、高血压、糖尿病和心、肝、肾功能减退。经彩超、CT、DSA等检查明确诊断。二、手术方法在DSA室 ,全麻下 ,患者仰卧位 ,先经股动脉穿刺插管 ,行腹主动脉造影 ,明确并测量AAA的病变情况及相关参数 ,决定内支架的类…  相似文献   

11.
目的探讨肾动脉瘤血管腔内治疗的临床护理规范措施。方法回顾解放军总医院血管外科自2010年1月-2011年8月收治的肾动脉瘤患者的临床资料,总结肾动脉瘤规范护理观察要点及相应处理措施。结果本组共9例患者,其中6例行栓塞术,2例行支架植入术,1例行支架植入术联合弹簧圈栓塞。患者平均住院(10±2)d,1例出现术后尿潴留,1例术后腹膜后出血其余患者未发生与医疗及护理相关并发症。结论加强肾动脉瘤的规范化护理有助于提高患者手术耐受性,能有效预防并发症的发生。  相似文献   

12.
目的探讨严重创伤院内急救初始阶段进行时效管理时对护理的要求及护理对策。方法回顾分析了2006年3月~2011年12月374例(研究组)和2005年i月~2006年3月26例(对照组)严重创伤患者的急救情况,对两组的护理策略、救治时间和其它临床资料予以对照研究。结果两组基本资料具有可比性(P〉0.05);研究组374例死亡20例,死亡率为5.35%,对照组26例死亡3例,死亡率为11.54%(P〈0.05)。研究组在急诊室处理时间、特殊检查时间、人院至手术室时间较对照组明显缩短(P〈0.05)。结论严重创伤急救绿色通道缩短了救治空间和时间,对护理急诊意识、急诊相应技术和多部门间(比如急诊科与手术室)组织协调能力提出了更高的要求。  相似文献   

13.
目的 系统评价应用“烟囱”技术治疗近肾腹主动脉瘤的安全性及有效性.方法 收集2003年-2014年已发表的关于应用烟囱技术腔内修复近肾腹主动脉瘤,同时保留内脏分支动脉的文献,回顾性分析技术成功率、血管通畅率、内漏发生率、并发症及病死率等近中期临床结果.结果 共纳入12篇文献的277例近肾腹主动脉瘤患者,技术成功率为93%,早期Ⅰ型内漏率为6%,脑卒中和心肌梗死的发生率均为3.90%;平均随访时间为13.6个月,血管通畅率为98%,共35例患者出现随访期内漏(Ⅰ型内漏10例,Ⅱ型内漏25例,无Ⅲ型内漏),随访期Ⅰ型内漏率为2%,肾功能损害发生率为12%,30 d病死率和随访期病死率分别为2.89%和8.38%.结论 应用烟囱技术治疗近肾腹主动脉瘤技术成功率较高,并发症率及病死率较低.  相似文献   

14.
目的 比较胸主动脉腔内修复术(TEVAR)联合药物及单纯药物在稳定型Standford B型主动脉夹层治疗中的价值,探讨稳定型B型主动脉夹层治疗策略.方法 回顾性分析2004年至2015年收治的118例明确诊断为稳定型B型主动脉夹层患者临床资料,其中接受TEVAR联合药物治疗(TEVAR组)57例,单纯药物治疗(药物组)61例.分别统计1个月内、随访期并发症和死亡率,Kaplan-Meier生存曲线比较两组生存率.结果 术后1个月内及住院期间主要并发症发生率、死亡率,TEVAR组分别为5.2%、0%,药物组均为0%.术后随访1~110个月,平均(43.3±36.7)个月,主要并发症、死亡率在TEVAR组分别为7.0%、5.3%,药物组分别为6.6%、8.1%;术后1、2、4、7年累积生存率在TEVAR组分别为100%、97.1%、93.5%、78.0%,药物组分别为98.4%、96.4%、90.8%、72.7%,两组间差异无统计学意义(x2=0.019,P=0.890).结论 与单纯药物治疗相比,TEVAR术治疗稳定型Standford B型主动脉夹层可降低假腔扩展率,但有手术相关并发症,并不能提高生存率.  相似文献   

15.
16.
PurposeTo characterize the short-term results of a newly available self-expanding covered stent (Covera; CR Bard Peripheral Vascular Inc., Murray Hill, New Jersey) for the reconstruction of target vessels in complex aneurysms.Materials and MethodsFrom August 2017 to November 2018, this self-expanding covered stent was used in 17 patients (mean 72.6 ± 7.6 years of age) during endovascular aneurysm repair (EVAR) with hypogastric preservation (11.8%), branched EVAR (29.4%), fenestrated (F)-EVAR (17.6%), chimney + F-EVAR (11.8%), or chimney EVAR (29.4%). In more than 48 stented arteries (2.8 ± 1.1/patient), 25 were preserved using this self-expanding covered stent.ResultsAll target vessels were successfully preserved. There was no 30-day mortality and 1 in-hospital death. Intraoperative aneurysm exclusion was successful in 14 patients (82.4%) with a perioperative technical success rate of 82.4%. The actuarial survival rate was 93.8% at 6 months and 85.9% at 12 months. Aneurysm sac regression of >5 mm was observed in 4 cases (23.5%), and the sac remained stable in the remaining patients (13 cases [76.5%]). At 12 months, the primary clinical success rate was 76.5%, and assisted primary clinical success rate was 82.4%. No type 3 endoleak was related to a disruption of the reconstruction with the self-expanding covered stent.ConclusionsThis new self-expanding covered stent provides good short-term patency in chimneys, branches, or fenestrations. Larger series with long-term follow-up are required to determine if the stent can sustain the mechanical stress to which it will be submitted in these repairs.  相似文献   

17.

Purpose

To evaluate the effectiveness and durability of intra-arterial aneurysm sac embolization for the treatment of type Ia endoleak after endovascular aneurysm repair (EVAR).

Materials and Methods

From February 2011 to December 2016, 22 patients underwent embolization of a type Ia endoleak after EVAR. Four patients (18%) were treated during the index EVAR and 18 (82%) in follow-up. Five patients (23%) were treated urgently and 17 (77%) electively. The embolization was performed with the use of liquid embolic agent, coils, and/or plugs. Adjunctive neck procedures were performed in 55% (n = 12) of the patients. The primary endpoint of this study was freedom from sac enlargement. Key secondary endpoints were technical success and freedom from endoleak-related reinterventions.

Results

Technical success was 100%. The 30-day mortality was 5% (n = 1; acute coronary syndrome). At a mean follow-up of 15.4 months (range 0.1–65.4) the freedom from sac enlargement rate was 76% (16 out of 21). Reintervention-free survival rates at 6, 12, and 24 months were 80%, 68% and 68%, respectively.

Conclusions

In patients with persistent type Ia endoleak the embolization of the aneurysm sac with or without adjunctive neck procedures can be safely performed, leading to acceptable clinical and radiologic outcomes.  相似文献   

18.
目的:探究在精神分裂症患者的临床治疗中临床护理路径标准化管理中的应用情况。方法选取精神病科接受治疗的精神分裂症患者124例进行分组护理,对照组患者在治疗期间实施常规护理,观察组患者则结合临床护理路径进行标准化管理。结果观察组患者在出院后其NOSIE量表评分明显优于对照组,同时观察组患者的护理满意度和护理差错事件发生率均显著优于对照组,差异显著符合统计学评估标准(P<0.05)。结论在精神分裂症患者的临床治疗中结合临床护理路径实施标准化管理能够显著改善患者的观察量表,同时提升护理满意度,降低护理不良事件发生率。  相似文献   

19.

Purpose

To evaluate long-term efficacy of translumbar embolization of type II endoleaks exclusively supplied by the lumbar arteries in patients with growing abdominal aortic aneurysm sacs using N-butyl cyanoacrylate (NBCA) instilled via percutaneous needle access.

Materials and Methods

The study included 25 patients who developed type II endoleak after endovascular aneurysm repair. Inclusion criteria for intervention were defined as sac expansion > 5 mm detected with CT angiography at 6-month follow-up or later. Translumbar infusion of NBCA directly into the patent portion of the aneurysm sac was performed in all cases. Duplex US was performed the day after the intervention, and CT angiography was performed within the first month. Subsequently, duplex US was performed at 3, 6, and 9 months, and CT angiography or CT was performed at 12 months and annually thereafter.

Results

Translumbar embolization was achieved in all 25 patients. The endoleak resolved in 22 patients (88%) on duplex US performed 1 day after the embolization procedure. Three patients with persistent endoleak (12%) required repeat embolization. Two complications were detected and were managed conservatively.

Conclusions

This study demonstrates the safety and efficacy of NBCA injection for treatment of type II endoleaks. This technique provides another option for the management of type II endoleaks.  相似文献   

20.

Purpose

To review short-term and midterm results of the fenestrated Anaconda stent graft in management of patients with pre-existing endovascular aortic stent graft and persistent type 1a endoleak.

Materials and Methods

This single-center retrospective study assessed all consecutive patients with type 1a endoleak and pre-existing endovascular aneurysm repair (EVAR) treated with fenestrated Anaconda stent grafts. Ten patients (9 males; mean age 78 y) with mean follow-up of 22.4 months ± 13 were included. Average aneurysm size was 80.1 mm (range, 62–101 mm). Mean time for conversion to fenestrated EVAR following original EVAR was 53.7 months (range, 22–101 months; median 54 months). Technical and clinical success; anatomic features, including aortic tortuosity, side vessel angulation, and stenosis; complications; and reinterventions were recorded.

Results

The technical success rate was 90%. There was no open conversion and no 30-day mortality, leading to a clinical success rate of 100%. Five of 10 patients demonstrated an aortic tortuosity index of grade 2 or 3. Additional hostile anatomy that made side vessel catheterization challenging was observed in 15 vessels (45%) with a stenosis of ≥ 50% (related to atherosclerotic disease or struts of indwelling prosthesis) and 21 vessels (66%) with ≤ 70° angulation. Two reinterventions, renal artery stent angioplasty and renal artery covered stent extension, were observed at 2 and 13 months.

Conclusions

Use of the fenestrated Anaconda endograft in patients with type 1a endoleaks following previous EVAR is safe, feasible, and offers some technical features that facilitate overcoming certain anatomic difficulties.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号